N
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- 8-K55.9 KBNOVADEL PHARMA INCMar 21, 4:36 PM ET·0000930413-12-001712
- SC 13D/A223.3 KBNOVADEL PHARMA INCFeb 13, 5:13 PM ET·0000932440-12-000064
- 8-K46.6 KBNOVADEL PHARMA INCFeb 8, 5:10 PM ET·0000930413-12-000552
- 8-K13.4 KBNOVADEL PHARMA INCFeb 1, 1:51 PM ET·0000930413-12-000426
- 8-K/A19.3 KBNOVADEL PHARMA INCJan 31, 12:52 PM ET·0000930413-12-000409
- 8-K53.8 KBNOVADEL PHARMA INCJan 20, 4:42 PM ET·0000930413-12-000239
- 8-K181.9 KBNOVADEL PHARMA INCJan 19, 3:22 PM ET·0000930413-12-000215
- 8-K40.1 KBNOVADEL PHARMA INCNov 14, 9:41 AM ET·0001043873-11-000079
- 8-K184.8 KBNOVADEL PHARMA INCNov 1, 4:21 PM ET·0001043873-11-000077
- 10-Q1.7 MBNOVADEL PHARMA INCNov 1, 12:02 PM ET·0001193125-11-290188
Insiders
10- Abd El-Shafy MohammedVP, Pharmaceutical Development
- Baric Mark JDirector
- Bergstrom David HChief Operating Officer
- BIOMEDICAL INVESTMENT GROUP LLCJoint Filer
- Bonney Thomas EDirector
- Cohen BarryVP, Product & Business Dev
- FRYDMAN JEAN WVP & General Counsel
- HAMILTON WILLIAM F PHDDirector
- Johnson Craig ASr. VP, CFO and Secretary
- KESSEL LARRYDirector
Tickers
No tickers on record
Addresses
business
1200 ROUTE 22 EAST SUITE 2000
BRIDGEWATER, NJ, 08807
mailing
1200 ROUTE 22 EAST SUITE 2000
BRIDGEWATER, NJ, 08807
Former Names
- FLEMINGTON PHARMACEUTICAL CORP2002-10-03